Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
Background: There has been considerable interest in the use of antimicrobial peptides (AMPs) as antimicrobial therapeutics in many conditions including cystic fibrosis (CF). The aim of this study is to determine if the prodrugs of AMPs (pro-AMPs) can be delivered to the lung by a vibrating mesh nebu...
Main Authors: | Éanna Forde, Graeme Kelly, Louise Sweeney, Deirdre Fitzgerald-Hughes, Ronan MacLoughlin, Marc Devocelle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/5/239 |
Similar Items
-
Respiratory Delivery of <i>Lacticaseibacillus rhamnosus</i> GG by Vibrating-Mesh and Jet Nebulisation
by: Alex Seungyeon Byun, et al.
Published: (2024-10-01) -
Performance Characterisation of the Airvo2<sup>TM</sup> Nebuliser Adapter in Combination with the Aerogen Solo<sup>TM</sup> Vibrating Mesh Nebuliser for in Line Aerosol Therapy during High Flow Nasal Oxygen Therapy
by: Ronan MacLoughlin, et al.
Published: (2024-04-01) -
Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
by: Elena Fernández Fernández, et al.
Published: (2021-04-01) -
Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
by: James A. McGrath, et al.
Published: (2019-02-01) -
Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era
by: Piers J. Naughton, et al.
Published: (2021-09-01)